Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albiglutide Monotherapy in Type 2 Diabetes (HARMONY 2)
NCT00849017Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2009
- Primary completion
- Nov 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 3 trial of albiglutide in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Jan 2009; status: completed.
02
Drugs
albiglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00849017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00849017.